Mwanasha Merrill, MD
Assistant Clinical Professor, Dept. of Medicine, Div. of Hematology & Oncology, UCSF
Education
- 2011, BA with honors, Neuroscience
Amherst College, Amherst, MA - 2018, MD, Medicine
Tufts University School of Medicine, Boston, MA - 2021, Resident, Internal Medicine
Beth Israel Deaconess Medical Center, Boston, MA - 2024, Clinical Fellow, Hematology & Oncology
Dana-Farber Cancer Institute/Massachusetts General Brigham, Boston, MA
Honors & Awards
- 2020-2021
ASH Minority Resident Award recipient - 2021
ASCO Conquer Cancer Resident Award recipient - 2022
JCO Trainee Reviewer Mentoring Program - 2023
ASH Minority Hematology Fellow Award recipient
Selected Publications
- Patell R, Khan AM, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI. Heparin induced thrombocytopenia antibodies in Covid-19. Am J Hematol. 2020 Jul 13. PMID: 32658337, PMCID: PMC7405086, https://doi.org/10.1002/ajh.25935
- Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost. 2020 Sep;18(9):2349- 2357. PMID: 32692862, PMCID: PMC7405046, https://doi.org/10.1111/jth.15018
- Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020 Sep 10;136(11):1342-1346. PMID: 32766883, PMCID: PMC7483433, https://doi.org/10.1182/blood.2020007938
- Koh MJ, Merrill MH, Koh MJ, Stuver R, Alonso CD, Foss FM, Mayor AM, Gill J, Epeldegui M, Cachay E, Thorne JE, Silverberg MJ, Horberg MA, Atlhoff KN, Nijhawan AE, McGinnis KA, Lee JS, Rabkin CS, Napravnik S, Li J, Castilho JL, Shen C, Jain S. Comparative Outcomes for Mature T and NK/T-cell Lymphomas in People with and without HIV and to AIDS-Defining Lymphomas. Blood Adv. 2022 Jan 13:bloodadvances.2021006208. doi: 10.1182/bloodadvances.2021006208. In Press.
- Stuver R, Merrill M, Jain S. Chapter 17: Hepatosplenic T-cell Lymphomas. In Kim WS, Zinzani PL, O'Connor OA, eds. The Peripheral T-Cell Lymphomas. 1st ed. Wiley; 2021: 225-231. In Press.
- Merrill MH, Dahi PB, Redd RA, et al. A Phase 2 Study of Pembrolizumab (MK-3475) after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma. Blood. 2022;140(Supplement 1):1185- 1187. doi:10.1182/BLOOD-2022-164839
- Qualls DA, Lambert N, Caimi PF, Merrill M et al. Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study. Blood. 2023;142(26):2327-2331. doi:10.1182/blood.2023021274